Dib Chakif

Dr. Dib Chakif

Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
PBPeter Bigler
Peter Bigler
IGIlche Gjuroski
Ilche Gjuroski
DCDib Chakif
Dib Chakif
Julien FurrerJulien Furrer
Julien Furrer
The proposed broadband attached proton test sequence allows the user to easily record 13C nuclear magnetic resonance multiplicity-edited and quaternary-carbon-only spectra. Compared to earlier attached proton test experiments, it preserves both a tolerance for wide ranges of one-bond-coupling constant values and the effective suppression of residual CHn signals in the quaternary-carbon-only spectra. The recording of edited spectra or quaternary-carbon-only spectra is made easy by a single, user-controllable constant. These attributes make the broadband attached proton test experiment attractive for the 13C analysis of small molecules, including spectral editing, particularly in high-throughput analysis laboratories.

Verified
Journal Article
Open access
PDF file
DCDib Chakif
Dib Chakif
Julien FurrerJulien Furrer
Julien Furrer
Heavy metals including mercury (Hg), lead (Pb), cadmium (Cd), and arsenic (As) remain significant global toxins due to their environmental persistence, widespread anthropogenic release, and serious biological effects. This review consolidates current understanding of their natural and industrial sources, environmental cycling, human exposure routes, and population-level vulnerabilities. It covers their toxicokinetics and toxicodynamics, emphasizing species-specific absorption, distribution, and injury mechanisms, including oxidative stress, thiol binding, mitochondrial dysfunction, endocrine disruption, and cancer risk. Clinical signs range from subtle neurocognitive impairment and kidney damage to severe acute poisoning. The review evaluates evidence-based approaches to risk assessment and biomonitoring, such as blood, urine, hair, and speciation tests, noting issues, including unvalidated provoked testing. Treatment focuses on removing exposure, providing nutritional support, and offering supportive care, with chelation therapy reserved for specific cases. It explains the chemistry, pharmacology, and roles of chelating agents—ALA, DMSA, DMPS, Cys, GSH, and physiologic thiols, comparing their effectiveness, limitations, and costs for various metals. Emerging therapies, precision toxicology, and public health strategies are discussed within a prevention-focused context. Unlike prior reviews focused primarily on toxic mechanisms or isolated clinical management, this review integrates mechanistic toxicology, biomarker interpretation and speciation, evidence-based clinical care, and ethical, cost-conscious decision-making within a single translational framework. This narrative review synthesizes foundational and contemporary literature published through 2025, with particular emphasis on studies published since 2000 that inform toxicokinetics, biomarker interpretation, diagnostics, clinical management, and prevention.

27 February 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
DCDib Chakif
Dib Chakif
JFJulien Furrer
Julien Furrer
Neurological disorders like Alzheimer’s, Parkinson’s, multiple sclerosis, and primary psychiatric conditions are complex, arising from a mix of genetic and modifiable risks. Growing evidence indicates that nutrition, environment, and lifestyle significantly influence disease development, progression, and treatment response. Nutrients such as vitamins, minerals, omega-3 fatty acids, and polyphenols affect neuroinflammation, oxidative stress, mitochondrial health, and neurotransmitter function. Dietary patterns like the Mediterranean and ketogenic diets offer protective benefits in clinical and experimental contexts. Meanwhile, environmental neurotoxicants–air pollution, heavy metals, pesticides, and endocrine disruptors contribute to neurodegeneration via oxidative damage, synaptic impairment, and epigenetic alterations. Lifestyle factors, such as physical activity, sleep, stress, and substance use, affect brain plasticity, neurogenesis, and metabolic health, thereby influencing disease progression over time. These factors often share common pathways such as oxidative stress, inflammation, vascular injury, mitochondrial dysfunction, and protein misfolding, underscoring the need for a comprehensive prevention and treatment strategy. Emerging therapies now incorporate personalized nutrition, lifestyle changes, and environmental risk mitigation alongside traditional drugs, supported by advances in multi-omics, digital health, and systems biology. Public health efforts to reduce neurotoxic exposure and encourage healthy habits further strengthen these approaches. This review summarizes existing mechanistic and clinical knowledge, with a focus on the potential of nutritional, environmental, and lifestyle interventions in neurological diseases. It also outlines the future research required to enhance precision neurology and strategies for brain health prevention.

Verified
Journal Article
Open access
PDF file
LPLeonidas D. Panos
Leonidas D. Panos
DCDib Chakif
Dib Chakif
Mechanical thrombectomy has significantly improved outcomes for patients with large-vessel occlusion stroke. However, restoring the artery does not always re-establish full microvascular blood flow, tissue rescue, or a good neurological outcome. Ischemia–reperfusion injury varies over time, with distinct biochemical mechanisms dominating during ischemia, early reperfusion, and the subsequent hours. During ischemia, factors like adenosine triphosphate (ATP) depletion, ionic imbalance, calcium overload, mitochondrial dysfunction, acidosis, and metabolic changes such as succinate build-up render brain tissue highly vulnerable. When blood flow resumes, oxygen delivery to this stressed tissue can induce rapid mitochondrial redox shifts, electron leakage, reactive oxygen and nitrogen species formation, iron-dependent radical generation, and lipid peroxidation. Damage may then persist for hours through ongoing mitochondrial dysfunction, phospholipid hydroperoxide accumulation, reactive aldehydes, ferroptosis, blood–brain barrier breakdown, microvascular issues, and inflammation. Much of the mechanistic evidence supporting these processes derives from experimental studies, and their relevance to clinical outcomes after thrombectomy requires further validation. This narrative review tracks these chemical changes across the main phases of cerebral ischemia–reperfusion injury and connects them to modern thrombectomy practices. It also explores how the timing of each process may inform neuroprotective strategies, drug delivery methods, patient selection via imaging, and future clinical trial approaches.